#202 – Rick Doblin: Psychedelics
Lex Fridman Podcast
MDMA and PTSD: A Clinical Breakthrough
This chapter explores a pivotal phase three study on MDMA as a treatment for PTSD, discussing the extensive research and trial phases required to develop effective psychedelic therapies. It highlights the challenges of conducting double-blind studies and maintaining anonymity among participants while examining the safety and efficacy of MDMA compared to traditional SSRIs. Insights from the study also reveal the complexities of therapeutic experiences and the unexpected effects of placebos in treatment settings.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
